Developing a vaccine for parvovirus B19
Official title: Task V06: Process development and manufacture of cGMP compliant parvovirus B19 vaccine drug product for use in Phase I/II clinical trials
Funded at Advanced Bioscience Laboratories, INC. · NIH-10001092 · Data updated 2026-11-12
This study is working on creating a vaccine to help protect people from parvovirus B19, which can lead to serious health problems, and it's designed for those who might benefit from this protection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2019 |
| Award (this year) | $2,093,700 |
| NIH project number | 272201800009I-0-759301900132-1 |
| Project ID | NIH-10001092 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk of parvovirus B19 infection, including those with weakened immune systems or certain blood disorders.
✕Less likely to help
Patients who are already immune to parvovirus B19 or those with unrelated health conditions may not receive benefit from this research.
What this research studies
This research focuses on the development and manufacturing of a vaccine for parvovirus B19, which is an infectious disease. The project involves creating a drug product that meets stringent cGMP compliance for use in early-phase clinical trials. Patients may benefit from the vaccine as it aims to provide protection against parvovirus B19, which can cause serious health issues. The research includes thorough planning, optimization, and regulatory support to ensure the vaccine's safety and efficacy.
Why it matters
Potential benefit: If successful, this research could lead to a new vaccine that protects against parvovirus B19, potentially reducing the incidence of related infections.
How similar studies have gone: Other vaccine development efforts have shown success in similar approaches, indicating a promising potential for this research.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Fouts, Timothy — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Timothy
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing new vaccines and biologics for infectious diseases
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.